Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • IHH Healthcare...

    IHH Healthcare Rebrands Global Hospitals as Gleneagles for Consolidation in India

    Written by savita thakur thakur Published On 2017-03-15T11:06:43+05:30  |  Updated On 14 Aug 2021 12:03 PM IST

    In order to make its presence stronger in the Indian hospital business, IHH Healthcare Berhad, Asia's largest private healthcare group has been re-branding Global Hospitals under the brand Gleneagles. It is reported that IHH is a majority investor in Gleneagles.


    Medical Dialogues team had earlier reported that IHH sold six percent stake of it in Apollo Hospitals Enterprise for Rs 1,070 crore ($160 million) primarily to run its own Hospital business in India.


    Read also: Apollo Hospitals 6 percent stake sold for Rs 1,070 crore


    IHH has currently has five brands in in its bucket- Mount Elizabeth, Gleneagles, Pantai, Parkway and Acibadem.


    Speaking about their re-branding idea under 'Gleneagles' an IHH official told Business Standard, "We are further consolidating our India platform by re-branding our Global Hospitals facilities under the IHH 'Gleneagles' brand. This will drive greater brand equity."


    IHH Healthcare currently has 10 operating hospitals in India, including Apollo Gleneagles Hospital in Kolkata, which is a joint venture with Apollo Hospitals. With the re-branding, nine out of the 10 operating hospitals that it has in India will have the brand Gleneagles attached to them. This includes eight Global Hospitals which will be known as Gleneagles Global Hospitals. Continental Hospitals, in which the company acquired a 51 per cent stake in 2015 for Rs 282 crore, has not been re-branded so far, reports Business Standard.


    In August 2015, IHH Healthcare had also acquired a 73.4 per cent stake in Ravindranath GE Medical Associates Pvt Ltd, which had hospitals under the brand Global Hospitals, for Rs 1,284 crore.


    Speaking with BS, an analyst from Hong Leong Investment Bank said, "We foresee that there is a potential for the group to divest the remaining stake of 4.78 per cent in the near future as the group consolidates and rationalises its investments in their fourth home market."


    While talking about their expansion in India, the IHH official said, "We are excited that India is now our fourth home market after we successfully re-calibrated our growth strategy here, learning from our Khubchandani experience to focus on brown field products."


    Regarding disinvestment in Apollo, the official said, "We have nothing new to add on our 6.07 per cent equity interest divestment in Apollo Hospitals Enterprise. We are retaining our remaining 4.78 per cent stake for the moment."




    ExpansionGleneaglesGlobal HospitalsIHHIHH Healthcare BerhadInvestor
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok